| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 04/17/2008 | CA2666184A1 The use of a dna damaging agent and a ligand for the treatment of cancer |
| 04/17/2008 | CA2664826A1 Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications |
| 04/16/2008 | EP1909855A2 A radioactive surface source and a method for producing the same |
| 04/16/2008 | EP1909854A1 Method for treating cancer |
| 04/16/2008 | EP1824525B1 STABILISED 99mTC COMPOSITIONS |
| 04/16/2008 | EP1509255B1 Methods and compositions for intravesical therapy of bladder cancer |
| 04/16/2008 | EP1250091B1 Hydrophilic cyanine dyes |
| 04/16/2008 | CN100381196C Method of obtaining gallium-68 and use thereof and device for carrying out said method |
| 04/16/2008 | CN100381177C Vitamin receptor binding drug delivery conjugates |
| 04/15/2008 | US7358379 Steroid conjugates, preparation thereof and the use thereof |
| 04/15/2008 | US7357928 Proteins for treatment of cancer by administering antinucleolin |
| 04/15/2008 | US7357915 Method of imaging cell death in vivo |
| 04/15/2008 | US7357914 Use of metal chelates in human or animal feeding |
| 04/15/2008 | US7357913 Methods for detecting, prognosing, or monitoring a disorder by comparing relative flux rates of two or more biological molecules in vivo |
| 04/10/2008 | WO2008041235A1 Fluorescent ruthenium compounds for detecting calcium binding proteins |
| 04/10/2008 | WO2008040441A2 Silicon derivatives for pet imaging |
| 04/10/2008 | WO2007066119A3 Novel imaging agents for fibrosis |
| 04/10/2008 | US20080085984 Producing carrier free, high purity, reduced side effects tumor imaging agent; reacting polydibutylchlorostannyl ethylstyrene with 1-(3-bromobenzyl)-2,2,5,5-tetramethyl-1,2,5-azadisilolidine then cyanamide |
| 04/10/2008 | US20080085240 by determining the relative amount of metabolite CO2 isotope exhaled; to assess the metabolic activity of drug metabolizing enzyme; theranostics; pharmacogenetics |
| 04/10/2008 | US20080085239 complex with radioisotope; anticancer radiopharmaceutical; diagnosis of tumors |
| 04/10/2008 | US20080085238 to detect amyloid deposits prior to aggregation into plaques; labeled bifunctional compound binds to target protein and to chaperone protein; Alzheimer's; 1-[4-(carboxymethoxy)phenyl]-3-(3,4-dimethoxy-phenyl)-1-propanyl-1-(3,3-dimethyl-1,2-dioxopentyl)-2-piperidinecarboxylate isomers bind differently |
| 04/10/2008 | US20080085237 Such as pyrrolidine, piperidine, piperazine and azapane moieties in halogenated 2-nitromidazoles; water soluble for easier administration, lower background noise, concentrate in tissue for increased binding intensity and enhanced signal detection, bioavailability; tomography, magnetic resonance image MRI |
| 04/10/2008 | CA2664700A1 Silicon derivatives for pet imaging |
| 04/09/2008 | EP1908479A2 Anti-p53 Antibodies |
| 04/09/2008 | EP1907017A2 Use of dtbz for imaging endocrine pancreas and beta cell mass in type 1 diabetes |
| 04/09/2008 | EP1906990A1 Anticoagulation agent and uses thereof |
| 04/09/2008 | EP1906924A1 Bone marrow-directing drug delivery materials and their applications |
| 04/09/2008 | EP0693924B2 Methods for (in vivo) delivery of biologics and compositions useful therefor |
| 04/09/2008 | CN101160403A Molecules for transporting a compound across the blood-brain barrier |
| 04/09/2008 | CN101157649A 18F-Fallypride automatically synthesizing method |
| 04/09/2008 | CN101157648A Method for purifying 18F-Fallypride marker precursor compound |
| 04/09/2008 | CN101157644A Method for preparing adamantine disulfide tetroxide derivative |
| 04/09/2008 | CN101156953A A preparation method of memantine bi-sulfur bi-nitrogen derivates medicinal box marking by technetium |
| 04/08/2008 | US7355015 Matriptase, a serine protease and its applications |
| 04/08/2008 | US7354935 [18F][2-fluorodideuteromethoxy-5-(5-trifluoromethyl-tetrazol-1-yl)-benzyl]-([2S,3S]-2-phenyl-piperidin-3-yl)-amine; image of neurokinin-1 receptors using positron emission tomography; detection or quantification; bioassay; brain, tissues, inflammation where substance P is involved, Alzheimer's disease |
| 04/08/2008 | US7354567 Mixing radioactive Technetium ethylenedicystiene complex with N-[2-(1H-pyrrolylmethyl)]-N'-(4-penten-3on-2)-ethane-1,2-diamine, and incubating |
| 04/08/2008 | CA2302636C Imaging methods and compositions |
| 04/03/2008 | WO2007047668A3 Use of non-canonical amino acids as metabolic markers for rapidly-dividing cells |
| 04/03/2008 | US20080081037 Methods and Agents for Diagnosis and Prevention, Amelioration or Treatment of Goblet Cell-Related Disorders |
| 04/03/2008 | DE102006045603A1 New phenyl-carboxyl compounds useful in the preparation of 6-halo-3,4-dihydroxy-L-phenylalanine |
| 04/03/2008 | DE102004011720B4 Radiohalogenierte Benzamidderivate und deren Verwendung in der Tumordiagnostik und Tumortherapie Radio Halogenated benzamide derivatives and their use in tumor diagnosis and tumor therapy |
| 04/02/2008 | EP1905357A1 Method of imaging cell death in vivo |
| 04/02/2008 | EP1904460A1 Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy |
| 04/02/2008 | EP1904183A2 Imaging and therapeutic method using monocytes |
| 04/02/2008 | EP1708758A4 System and method for expression proteomics based on isotope ratio modification |
| 04/02/2008 | CN101155602A Caspase-3 substrate comprising imaging agents |
| 04/02/2008 | CN101155601A Bioactive stents for type ii diabetics and methods for use thereof |
| 04/02/2008 | CN101154476A Method for producing radiotracer |
| 04/02/2008 | CN101153013A Method of producing DL-tyrosine -**N |
| 04/02/2008 | CN100378109C Tetracyclic 3-substituted indoles having serotonin receptor affinity |
| 04/01/2008 | US7351790 Peptide-based compounds |
| 04/01/2008 | US7351691 Bactericides with antibacterial activity and an improved mammalian safety profile; exhibit reduced tissue accumulation and/or nephrotoxicity when administered to mammals |
| 04/01/2008 | US7351542 Methods of modulating tubulin deacetylase activity |
| 04/01/2008 | US7351401 Thioflavin derivatives for use in the antemortem diagnosis of Alzheimers disease and in vivo imaging and prevention of amyloid deposition |
| 04/01/2008 | US7351399 Conversion by human liver microsomes to MPO3H2; hepatitis, cancer, liver fibrosis, malaria, other viral and parasitic infections, and metabolic diseases where the liver is responsible for the overproduction of the biochemical end product, diabetes; enhanced oral drug delivery |
| 04/01/2008 | US7351398 Stabilization of radiopharmaceutical compositions using hydrophilic thioethers |
| 04/01/2008 | US7351397 Synergistic mixture of organosulfer compound and 6-hydroxychroman compound; radiolabelling efficiency and shelf-life of peptide and non-peptide radiopharmaceutical compositions may be significantly increased by addition of a stabilizing amount of a hydrophilic 6-hydroxy-chroman derivatives |
| 04/01/2008 | US7351389 Aminocarboxylate ligands having substituted aromatic amide moieties |
| 04/01/2008 | CA2279293C Hexahydroindenopyridine compounds having antispermatogenic activity |
| 03/27/2008 | WO2008036449A2 Chemical antibodies for immunotherapy and imaging |
| 03/27/2008 | WO2008036147A2 Drug delivery with stimulus responsive biopolymers |
| 03/27/2008 | US20080075660 Near infrared-fluorescence using phospholipid ether analog dyes in endoscopic applications |
| 03/27/2008 | US20080075659 Determining the percentage of monoclonal, chimerized, murine or humanized antibody greater than 90 percent using excess amount of CD66 antigen, and the percentage of immunoreactive antibody that binds specifically to CD66 |
| 03/27/2008 | US20080075658 Adsorbing a radionuclide onto activated charcoal, blending with an insoluble polymer powder and heating; gastrointestinal tract |
| 03/27/2008 | US20080075657 Forming a biocompatible hydrogel in situ; adding a liquid premix of alkylated chitosan and an oxidized polysaccharide in an aqueous medium into an intervertebral disc, hydrogel induces tissue growth within the disc |
| 03/26/2008 | EP1901783A1 Gentisic acid for stabilisig 123-i radiopharmaceuticals |
| 03/26/2008 | EP1620373B1 Device and method for the fluorination of nucleophiles |
| 03/26/2008 | EP0714405B1 Therapeutic and diagnostic agents for amyloidosis |
| 03/26/2008 | CN101151054A Radiofluorinated peptides |
| 03/26/2008 | CN101151053A Hybrid inorganic nanoparticles, methods of using and methods of making |
| 03/25/2008 | US7348413 Monoclonal antibodies for use in diagnosis, prevention and treatment of cell proliferfative disorders; immunotherapy; immunodiagnostics |
| 03/25/2008 | US7348313 Administering carrier molecule such as albumin conjugated to mannose-6-phosphate; particularly targeting Hepatic Stellate Cells (HSC); glomeruloscherosis, interstitial fibrosis, lung fibrosis, atherosclerosis, Crohn's disease, colitis ulcerosa, glomerulonephritis and sepsis; diagnosis |
| 03/25/2008 | CA2173319C Radiation sensitization using texaphyrins |
| 03/20/2008 | WO2008033561A2 Click chemistry-derived cyclopeptide derivatives as imaging agents for integrins |
| 03/20/2008 | WO2008031842A1 Inhibitors of gpr87 for cancer therapy |
| 03/20/2008 | WO2007115829A3 Anti ku70 internalizing antibodies |
| 03/20/2008 | WO2007100563A3 Bifunctional resorcinol, thioresorcinol, and dithioresorcinol derivative metal chelating conjugates |
| 03/20/2008 | US20080069816 Carcinoembryonic antigen (CEA); utilizes crystallographic structural data to select immunoglobulin framework having maximum structural overlap non-human donor molecule |
| 03/20/2008 | US20080069771 Oxygenated polymerized hemoglobin solutions and their uses for tissue visualization |
| 03/20/2008 | US20080069770 Monoclonal antibodies; used to modulate the immune system; no modulation of the totality of the T-cell population but only of the sub-assembly of T-cells expressing the beta sub-family specific to the T-cell receptors; used for organ transplant rejection |
| 03/20/2008 | CA2663454A1 Click chemistry-derived cyclopeptide derivatives as imaging agents for integrins |
| 03/19/2008 | EP1900379A2 Method for the selective and quantitative functionalization of immunoglobulin FAB fragments, conjugate compounds obtained with the same and composition thereof |
| 03/19/2008 | EP1900377A1 Inhibitors of GPR87 for cancer therapy |
| 03/19/2008 | EP1898962A1 Gastrin releasing peptide compounds |
| 03/19/2008 | EP1898961A1 Method and composition to individualize levodopa/carbidopa therapy using a breath test |
| 03/19/2008 | EP1898958A2 Supramolecular aggregates containing chelating agents and bioactive peptides as effective and selective delivery tools for drugs and contrast agents in mri or nuclear medicine |
| 03/19/2008 | EP1196083B1 Imaging the dopamine transporter to determine ad-hd |
| 03/19/2008 | CN101146822A EphB receptor-binding peptides |
| 03/19/2008 | CN101143899A Isotope 188Re labeled monoclonal antibody and application thereof |
| 03/19/2008 | CN101143897A Labeling technique for 99Tcm-His10-AnnexinV labeling compound and application of the same as developer in detecting cell apoptosis |
| 03/18/2008 | US7345151 Antagonists specific for denatured collagen and methods of using same |
| 03/18/2008 | US7344705 Composition comprising low density microspheres |
| 03/18/2008 | US7344702 Contrast agents for myocardial perfusion imaging |
| 03/18/2008 | US7344701 For conjugation with biomolecules, drugs, and toxins |
| 03/18/2008 | US7344700 Anticancer agents; sexual disorders; complexing drug to radioactive materials |
| 03/18/2008 | US7344699 Drug conjugate comprising an erythropoietin receptor ligand and an anticancer agent |
| 03/18/2008 | US7344698 Emulsion containing nanoparticles in perfluorohydrocarbon solvent; antiinflammatory agents; antitumor agents |
| 03/18/2008 | CA2185043C Monoclonal antibodies recognizing tie-receptor and their use |
| 03/13/2008 | WO2008028688A2 Compounds and methods for 18f labeled agents |
| 03/13/2008 | WO2008028534A1 Aptamers labelled with gallium-68 |